Literature DB >> 17445109

Steroids and aseptic osteonecrosis (AON) in migraine patients.

Aamir Hussain1, William B Young.   

Abstract

Osteonecrosis is a bony infarction caused by disruption of blood supply to the bone. Aseptic osteonecrosis should be rare with intermittent use of steroids in disabling and refractory migraine cases. We present 3 cases of patients who had severe migraine and developed aseptic osteonecrosis with short-term, intermittent pulse doses of corticosteroids. Migraine has been mentioned as a possible risk factor for aseptic osteonecrosis, and we speculate that severe migraine may be a risk factor for developing aseptic osteonecrosis. Furthermore, migraineurs who develop aseptic osteonecrosis may or may not have associated white matter changes in the brain. We noted a triad of severe migraine, osteonecrosis, and migraine-related white matter lesions in only 1 case. In severe cases of migraine, steroids should be used cautiously.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445109     DOI: 10.1111/j.1526-4610.2006.00636.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  6 in total

Review 1.  Management of headache in the elderly.

Authors:  Matthew S Robbins; Richard B Lipton
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Treating migraine in the emergency department.

Authors:  Randolph W Evans
Journal:  BMJ       Date:  2008-06-09

Review 3.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

4.  Avascular necrosis after oral corticosteroids in otolaryngology: Case report and review of the literature.

Authors:  Patrick Kennedy; Ahmed Bassiouni; Alkis Psaltis; Jastin Antisdel; Joseph Brunworth
Journal:  Allergy Rhinol (Providence)       Date:  2016-01

5.  Secondary osteonecrosis of the knee as a part of long COVID-19 syndrome: a case series.

Authors:  Sanjay R Agarwala; Mayank Vijayvargiya; Tushar Sawant
Journal:  BMJ Case Rep       Date:  2022-03-29

6.  Post-infectious new daily persistent headache may respond to intravenous methylprednisolone.

Authors:  Sanjay Prakash; Nilima D Shah
Journal:  J Headache Pain       Date:  2010-02       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.